Fact CheckerSign in

NCT07454148Active, not recruiting

CART-BP Prospective Study for Hypertension Control

Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management in Korean Patients With Uncontrolled Hypertension: A Prospective Non-Randomized Study

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro(a brand name of cuffless ambulatory blood pressure monitoring device)-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAEs) are also assessed.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
288 (actual)
First submitted
2 Mar 2026
Start date
Mar 2025
Primary completion date
May 2026
Lead sponsor
Korea University Anam Hospital
NCT number
NCT07454148

What you commit to

  • Study type: Interventional
  • Participants enrolled: 288
  • From Mar 2025 to the primary completion date, May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of intolerance to olmesartan, amlodipine, or hydrochlorothiazide
  • Suspected secondary hypertension
  • Other serious medical condition that may interfere with study participation

Other

  • Atrial fibrillation
  • Pregnancy or lactation

Who the study is looking for

  • Age \>= 19 years
  • Office systolic blood pressure(BP) \>= 140 mmHg or diastolic BP \>= 90 mmHg
  • Able and willing to provide written informed consent and comply with follow-up visits

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Korea University Anam Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.